Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

NXGL

NEXGEL, INC.

Healthcare · Medical Instruments & Supplies

$0.18Sep 29, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

NEXGEL, INC. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +28% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +28% YoY in Q2 FY2026

Pipeline evidence · 0d ago

NXGL's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on NXGL.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full NXGL earnings analysis

Reported figures for NEXGEL, INC. — research only, not investment advice.

Revenue YoY
+28.1%

Latest Intelligence

Updated

What happened recently for NEXGEL, INC. (NXGL) — events, not interpretation.

Event
Reported Q2 2026 revenue +28% YoY.
Also
Last session September 29, 2026 at $0.18.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

NEXGEL, INC. (NXGL)

Healthcare · Medical Instruments & Supplies

Investment Snapshot above is the primary AlphaOS analysis for NEXGEL, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.72M
Revenue:
$3.69M

NXGL earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow NEXGEL, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.